GLP-1 RA Maintenance Patient Education: Risks vs benefits were laid out regarding maintenance therapy given at lower than manufacturer recommendations (manufacture recommendations recommend keeping the patient on at max dose (Semaglutide 2.4 mg/100 units per week or Tirzepatide 15 mg/week)
"Medicare GLP-1 Bridge." A short-term Part D demonstration beginning July 2026 offering ~$50/month access to eligible GLP-1s
Supplements to Limit or Avoid While on Tirzepatide High-dose antacids (calcium carbonate, aluminum hydroxide) can impair tirzepatide absorption and create a vicious cycle: they further reduce stomach acid, worsening nutrient deficiency
Just be sure to consult with an expert to create the best plan for you
Providers weigh risks carefully before approving treatment
You will learn the exact temperatures required for short-term and long-term storage, why your container choice matters more than you think, how bacteriostatic water extends shelf life compared to sterile water, and which specific peptides demand special attention